CTLA4 and neoplasm: Escape mechanisms include down-regulation of tumor antigens [2], alterations of target antigens by alternative splicing [3], activation of alternative signaling pathways, and overexpression of inhibitory signals (e.g., cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) or programmed cell death-1 (PD1)) [4].